PUT - SPRINTER OPEN END - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 11:32:06 26/06/2024 pm IST | ||
| 19.19 EUR | +0.95% |
|
| Current month | +2.68% | ||
| 1 month | -0.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 19.19 | +0.95% |
| 25/24/25 | 19.01 | +1.49% |
| 24/24/24 | 18.73 | -1.78% |
| 21/24/21 | 19.07 | +1.38% |
| 20/24/20 | 18.81 | -0.79% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 11:32 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8H82 |
| ISIN | DE000VQ8H822 |
| Date issued | 09/06/2021 |
| Strike | 425.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.47 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 23.14 € |
|---|---|
| Lowest since issue | 1.05 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
223.2
USD
Average target price
283.2
USD
Spread / Average Target
+26.87%
- Stock Market
- Certificates
- Certificat
